TREA

97353799 - AOBIOME

Follow

Information

  • Trademark
  • 97353799
  • Serial Number
    97353799
  • Registration Number
    7732497
  • Filing Date
    April 08, 2022
    3 years ago
  • Registration Date
    March 18, 2025
    12 months ago
  • Transaction Date
    March 19, 2025
    12 months ago
  • Status Date
    March 18, 2025
    12 months ago
  • Published for Opposition Date
    March 07, 2023
    3 years ago
  • Location Date
    February 25, 2025
    a year ago
  • First Use Anywhere Date
    September 12, 2024
    a year ago
  • First Use In Commerce Date
    September 12, 2024
    a year ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    BEN, LINDSEY
  • Attorney Docket Number
    N2060-2017
    Attorney Name
    Ann Lamport Hammitte
    Law Office Assigned Location Code
    L80
  • Owners
Information
Mark Drawing Code
4
Mark Identification
AOBIOME
Case File Statements
  • GS0051: Medicated gels for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated creams for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; medicated sprays for therapeutic use in the nature of therapeutic pharmaceuticals containing ammonia oxidizing bacteria for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; nasal sprays for therapeutic use; topical applications in the nature of gels, creams, sprays, and liquids for therapeutic use, namely, topical preparations containing ammonia oxidizing bacteria for the treatment of skin disorders, acne, inflammation, eye disorders, migraines, headaches, allergic reactions, insomnia, hypertension, thermoregulation, and to promote wound healing; medicated liquids for therapeutic use in the nature of therapeutic pharmaceuticals for the treatment of inflammatory diseases, for the treatment of systemic diseases, namely, hypertension, other cardiovascular and circulatory disorders, and primary and secondary headache disorders including migraine, and to counteract skin damage caused by UV exposure or aging; biological therapeutics being pharmaceutical preparations for treatment of skin disorders, circulatory and cardiovascular disorders, neurologic diseases, inflammation, gastrointestinal disorders, respiratory disorders, eye disorders, urogenital disorders, auditory disorders, migraines, headaches, allergic rhinitis, insomnia, hyperhidrosis, acne, and hypertension; therapeutic agents for thermoregulation and promoting wound healing
Case File Event Statements
  • 4/12/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 4/12/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 1/26/2023 - 3 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 1/27/2023 - 3 years ago
    4 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/15/2023 - 3 years ago
    5 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/7/2023 - 3 years ago
    6 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/7/2023 - 3 years ago
    7 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/2/2023 - 2 years ago
    8 - NOA E-MAILED - SOU REQUIRED FROM APPLICANT Type: NOAM
  • 10/24/2023 - 2 years ago
    9 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/24/2023 - 2 years ago
    10 - SOU EXTENSION 1 FILED Type: EXT1
  • 10/24/2023 - 2 years ago
    11 - SOU EXTENSION 1 GRANTED Type: EX1G
  • 10/26/2023 - 2 years ago
    12 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 5/2/2024 - a year ago
    13 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 5/2/2024 - a year ago
    14 - SOU EXTENSION 2 FILED Type: EXT2
  • 5/2/2024 - a year ago
    15 - SOU EXTENSION 2 GRANTED Type: EX2G
  • 5/3/2024 - a year ago
    16 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 10/31/2024 - a year ago
    17 - SOU TEAS EXTENSION RECEIVED Type: EEXT
  • 10/31/2024 - a year ago
    18 - SOU EXTENSION 3 FILED Type: EXT3
  • 10/31/2024 - a year ago
    19 - SOU EXTENSION 3 GRANTED Type: EX3G
  • 10/31/2024 - a year ago
    20 - NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Type: EXRA
  • 11/1/2024 - a year ago
    23 - USE AMENDMENT FILED Type: IUAF
  • 11/1/2024 - a year ago
    21 - TEAS STATEMENT OF USE RECEIVED Type: EISU
  • 1/17/2025 - a year ago
    22 - CASE ASSIGNED TO INTENT TO USE PARALEGAL Type: AITU
  • 1/18/2025 - a year ago
    24 - STATEMENT OF USE PROCESSING COMPLETE Type: SUPC
  • 2/25/2025 - a year ago
    26 - NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Type: SUNA
  • 2/25/2025 - a year ago
    25 - ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Type: CNPR
  • 3/18/2025 - 12 months ago
    27 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 3/18/2025 - 12 months ago
    28 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC